Liver Cancer Trial, Recruiting NCT06260943 Sponsor: University of Miami Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06260943
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Patients who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) and are already enrolled in, or eligible for, a specific liver disease registry at the trial site
  • Adults aged 18 or older who have been diagnosed with this type of liver cancer, confirmed through their medical records
  • People who personally identify as having had hepatocellular carcinoma (liver cancer) and wish to participate as advocates
  • People who identify as a caregiver or support person for someone with this type of liver cancer
  • Healthcare professionals such as doctors, social workers, nurse navigators, and research coordinators who are involved in caring for liver cancer patients
  • Anyone who is able and willing to give their agreement to participate in the study

Who may not be able to join:

  • People who are not able to speak either Spanish or English
  • People who have moderate or severe confusion or memory problems related to liver disease, or other significant cognitive (thinking) difficulties (confirm with trial site)
  • People who are unwilling or unable to give their own consent to participate
  • Anyone under 18 years of age, including infants, children, and teenagers
  • People who are currently incarcerated (in prison)

Note: Pregnant women are not excluded from this trial, though no information about pregnancy or the baby will be collected.


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patricia Jones, MD, University of Miami

Phone: (305) 243-0779

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 April 2024
Est. completion
31 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of Hours for Each Contact; Number of Days to First Contact; Number of Days to First Treatment; Number of Months of Total Navigation; Number of Participants that Die Within One Year; Proportion of Participants Enrolled in Clinical Research; Acceptability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov